SCHEDULE 13G

Statement of Beneficial Ownership

abrdn Life Sciences Investors Filed 2025-04-28 Acc 0001445546-25-002997

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-04-28 SCHEDULE 13G Statement of Beneficial Ownership
2025-04-21 4 10% owner sold 9,144 shares at $11.78 ($107,716)

Link to a passage

External

SEC EDGAR (opens in new tab)